ETFs by Holding
ETFs That Hold Moderna (MRNA)
Every fund in our data that holds MRNA as a top-10 position, with each fund's yield, fees and assets.
Holdings as of Oct 16, 2026 · 46 funds
Our holdings data as of Oct 16, 2026 lists 46 funds that hold MRNA as a top-10 position. LGHT (Langar Global HealthTech ETF) has the largest weighting at 18.0%.
By dollars invested, IBB holds the most MRNA: about $654M, 6.0% of its $10.8B in assets. The largest fund on the list by assets is RSP ($97.8B), with MRNA at 0.3%.
38 of the 46 funds pay a distribution; the highest current rate is ULTI at 69.60%. MRNA itself does not currently pay a dividend.
Largest MRNA holders by dollars invested
Diversified funds ranked by how much MRNA they own: assets under management times the MRNA weighting. A broad index fund with a modest weighting often owns more MRNA than every concentrated fund combined, so this order differs from the weighting table below. Leveraged and single-stock funds are left out because their reported weight is swap notional or a cash sleeve, not dollars of MRNA.
| Fund | Name | MRNA held | MRNA weight | AUM |
|---|---|---|---|---|
| IBB | iShares Biotechnology ETF | $654M | 6.04% | $10.8B |
| VBR | Vanguard Morningstar Small-Cap Value ETF | $381M | 1.07% | $35.6B |
| RSP | Invesco S&P 500® Equal Weight ETF | $313M | 0.32% | $97.8B |
| XBI | SPDR S&P Biotech ETF | $246M | 2.39% | $10.3B |
| IWS | iShares Russell Mid-Cap Value ETF | $119M | 0.78% | $15.3B |
| IDNA | iShares Genomics Immunology and Healthcare ETF | $36M | 11.32% | $317M |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | $35M | 1.67% | $2.1B |
| BBH | VanEck Biotech ETF | $33M | 6.93% | $482M |
| SPHB | Invesco S&P 500® High Beta ETF | $29M | 2.94% | $982M |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | $29M | 1.04% | $2.8B |
Funds with the most MRNA by weighting
Every fund in the data, sorted by MRNA weight. Click any header to re-sort, or open a fund for its full analysis.
| Fund | Name | MRNA weight | Strategy | Distribution rate | Expense ratio | AUM | Distribution Safety Score™ |
|---|---|---|---|---|---|---|---|
| LGHT | Langar Global HealthTech ETF | 17.97% | — | — | 0.85% | $2M | — |
| GNOM | Global X Genomics & Biotechnology ETF | 11.33% | — | 0.18% | 0.50% | $107M | 50 |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 11.32% | — | 0.62% | 0.47% | $317M | 69 |
| WDNA | WisdomTree BioRevolution Fund | 9.91% | — | 0.48% | 0.45% | $5M | 50 |
| MEME | Roundhill Meme Stock ETF | 9.67% | — | — | 0.69% | $12M | — |
| GNMX | Corgi Genomics & Precision Medicine ETF | 8.12% | — | — | 0.35% | $3M | — |
| BBH | VanEck Biotech ETF | 6.93% | — | 0.40% | 0.35% | $482M | 94 |
| IBB | iShares Biotechnology ETF | 6.04% | — | 0.02% | 0.44% | $10.8B | 84 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 5.92% | — | 0.40% | 0.19% | $113M | 94 |
| BBP | Virtus LifeSci Biotech Products ETF | 5.58% | — | — | 0.34% | $127M | — |
| NXTE | AXS Sustainable Alpha ETF | 5.43% | — | 0.40% | 1.00% | $53M | 72 |
| ULTI | REX IncomeMax Option Strategy ETF | 4.98% | Options income | 69.60% | 1.32% | $16M | 0 |
| BMED | BlackRock Future Health ETF | 4.95% | — | 0.23% | 0.55% | $14M | 50 |
| RKNG | Defiance Retail Kings ETF | 4.84% | — | — | 0.79% | $6M | — |
| BGCG | Baillie Gifford International Concentrated Growth ETF | 4.72% | — | — | 0.72% | $106M | — |
| BUZZ | VanEck Social Sentiment ETF | 4.70% | — | — | 0.76% | $102M | — |
| FCUS | Pinnacle Focused Opportunities ETF | 4.12% | — | 3.56% | 0.80% | $92M | 50 |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | 3.75% | — | 0.08% | 0.59% | $412M | 97 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 3.06% | Leveraged | 0.32% | 0.95% | $88M | 52 |
| SPHB | Invesco S&P 500® High Beta ETF | 2.94% | — | 0.40% | 0.25% | $982M | 74 |
| ANEW | ProShares MSCI Transformational Changes ETF | 2.75% | — | 0.22% | 0.45% | $8M | 52 |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 2.69% | — | 0.54% | 0.40% | $903M | 94 |
| ALTL | Pacer Lunt Large Cap Alternator ETF | 2.56% | — | 2.02% | 0.60% | $83M | 65 |
| FMED | Fidelity Disruptive Medicine ETF | 2.51% | — | — | 0.50% | $51M | — |
| XBI | SPDR S&P Biotech ETF | 2.39% | — | 0.07% | 0.35% | $10.3B | 72 |
| QQXT | First Trust NASDAQ-100 Ex-Technology Sector Index Fund | 2.36% | — | 0.78% | 0.57% | $141M | 79 |
| PALC | Pacer Lunt Large Cap Multi-Factor Alternator ETF | 2.07% | — | 1.64% | 0.60% | $197M | 72 |
| NIXT | Research Affiliates Deletions ETF | 2.05% | — | 1.08% | 0.19% | $40M | 85 |
| FCTR | First Trust Lunt U.S. Factor Rotation ETF | 1.95% | — | 0.75% | 0.65% | $50M | 49 |
| HTEC | Robo Global® Healthcare Technology and Innovation ETF | 1.95% | — | 0.81% | 0.68% | $102M | 50 |
| FDMO | Fidelity® Momentum Factor ETF | 1.80% | — | 0.72% | 0.15% | $882M | 82 |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 1.67% | — | 1.20% | 0.07% | $2.1B | 100 |
| IMCV | iShares Morningstar Mid-Cap Value ETF | 1.09% | — | 2.15% | 0.06% | $1.1B | 95 |
| VBR | Vanguard Morningstar Small-Cap Value ETF | 1.07% | — | 1.74% | 0.05% | $35.6B | 97 |
| GINN | Goldman Sachs Innovate Equity ETF | 1.05% | — | 1.16% | 0.50% | $189M | 76 |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 1.04% | — | 1.16% | 0.17% | $2.8B | 93 |
| RSPE | Invesco ESG S&P 500 Equal Weight ETF | 0.90% | — | 1.52% | 0.20% | $71M | 93 |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 0.78% | — | 0.96% | 0.18% | $501M | 98 |
| IWS | iShares Russell Mid-Cap Value ETF | 0.78% | — | 1.43% | 0.23% | $15.3B | 100 |
| CVMC | Calvert US Mid-Cap Core Responsible Index ETF | 0.70% | — | 1.27% | 0.15% | $115M | 99 |
| WSML | iShares MSCI World Small-Cap ETF | 0.70% | — | 1.72% | — | $657M | 50 |
| HIBL | Direxion Daily S&P 500® High Beta Bull 3X Shares | 0.63% | Leveraged | 0.18% | 0.98% | $80M | 24 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.56% | Leveraged | 0.05% | 0.96% | $620M | 9 |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 0.52% | — | 2.84% | 0.62% | $689M | 50 |
| RSP | Invesco S&P 500® Equal Weight ETF | 0.32% | — | 1.49% | 0.20% | $97.8B | 100 |
| RSPA | Invesco S&P 500 Equal Weight Income Advantage ETF | 0.23% | — | 9.28% | 0.29% | $1.2B | 95 |
Single-stock funds built on MRNA
These funds track Moderna directly: option-income funds that sell calls on it, and leveraged or inverse trackers. Many hold Treasuries and options rather than the shares, so they do not always appear in the holdings table above. A high distribution rate here is mostly option premium and can fall quickly.
How to read this list
- Holdings come from each fund's ten largest positions. A fund that holds MRNA at a smaller weight is not listed.
- Weights are as reported by each fund on or before Oct 16, 2026 and move with prices between reports. Distribution rates are annualized from each fund's latest payment.
- This is a list of exposure, not a recommendation. Open any fund for its full record.
Frequently asked questions
Which ETF has the most MRNA?
LGHT has the largest MRNA weighting in our data as of Oct 16, 2026, at 18.0%.
Which ETF holds the most MRNA in dollars?
IBB holds about $654M of MRNA: 6.0% of $10.8B in assets. A fund's weighting says how much of that fund is MRNA; the dollar figure says how much MRNA the fund owns, which is why a large index fund with a modest weighting can own more than every concentrated fund on the list.
How many ETFs hold MRNA?
46 funds hold MRNA as one of their ten largest positions in our data. Many more broad index funds hold it at smaller weights, which our top-10 holdings data does not cover.
Which ETFs that hold MRNA pay a dividend?
38 of the funds on this list pay a distribution. The highest current rates are ULTI (69.60%), RSPA (9.28%), FCUS (3.56%). Sort the table by distribution rate to see the rest.
Is there an ETF that pays income from MRNA?
2 single-stock funds are built on MRNA, including MRNY, MRNX. The option-income ones sell calls on MRNA for income and give up some of its upside; leveraged and inverse ones pay little or nothing.
Does MRNA pay a dividend?
No. Moderna does not currently pay a dividend, so a fund holding it earns no income from that position.